Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal

Diabetes

Volumn 45, Issue 12, 1996, Pages 1734-1743

  Hawkins, Meredith ^a   Barzilai, Nir ^a   Chen, Wei ^a   Angelov, Ivo ^a   Hu, Meizhu ^a   Cohen, Pinchas ^b   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLUCOSE; GLUCOSE 6 PHOSPHATE; HEXOSAMINE; INSULIN; SOMATOMEDIN C; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HORMONE ACTION; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0029860211     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.12.1734     Document Type: Article

References (35)

1. Garvey WT, Olefsky JM, Matthaei S, Marshall S: Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes: a new mechanism of insulin resistance. J Biol Chem 262:189-197, 1987
2. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating desensitization of the glucose transport system: role of hex osamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712, 1991
3. Robinson KA, Sens DA, Buse MG: Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Diabetes 42:1333-1346, 1993
4. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N: In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96:132-140, 1995
5. Crook ED, Zhou Z, Daniels MC, Neidigh JL, McClain DA: Regulation of glycogen synthase by glucose, glucosamine and glutamine:fructose-6-phosphate amidotransferase. Diabetes 44:314-320, 1995
6. Robinson KA, Weinstein ML, Lindenmeyer GE, Buse MG: Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44(12):1438-1446, 1995
7. Hebert LF, McClain DA: Overexpression of glutamine:fructose-6-phosphate amidotransferase in skeletal muscle of transgenic mice results in insulin resistance. Diabetes 44(1):47A, 1995
8. Baron AD, Zhu J-S, Zhu J-H, Weldon H, Maianu L, Garvey WT: Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle. J Clin Invest 96:2792-2801, 1995
9. Myers M, Sun XJ, Cheatham B, Jachna B, Glasheen E, Backer J, White M: IRS-1 is a common element in insulin and IGF-1 signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132(4): 1421-1430, 1993
10. Rossetti L, Frontoni S, Dimarchi R, DeFronzo R, Giaccari A: Metabolic effects of IGF-1 in diabetic rats. Diabetes 40:444-448, 1991
11. Jacob RJ, Sherwin RS, Bowen L, Fryburg D, Fagin KD, Tamborlane WV, Shulman GI: Metabolic effects of IGF-1 and insulin spontaneously diabetic BB/w rats. Am J Physiol 260:E262-E268, 1991
12. Usala A-L, Madigan T, Burguera B, Sinha M, Caro J, Cunningham P, Powell J, Butler P: Treatment of insulin-resistant diabetic ketoacidosis with IGF-1 in an adolescent with insulin-dependent diabetes. N Engl J Med 327(12):853-857, 1992
13. Morrow LA, O'Brien MB, Moller DE, Flier GS, Moses AC: Recombinant human insulin-like growth factor-1 therapy improves glycemic control and insulin action in the type A syndrome of insulin resistance. J Clin Endocrinol Metab 79(1):205-210, 1994
14. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS: Comparison of the metabolic effects of recombinant human insulin-like growth factor-1 and insulin: dose-response relationships in healthy young and middle-aged adults. J Clin Invest 93:1131-1139, 1994
15. Sasoaka T, Kobayashi M, Takata Y, Ishibashi O, Iwasaki M, Shigeta Y, Goji K, Hisatomi A: Clarification of signaling pathways mediated by insulin and insulin-like growth factor-1 receptors in fibroblasts from patients with specific defect in insulin receptor. Diabetes 37:1515-1523, 1988
16. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
17. Rossetti L, Laughlin MR: Correction of chronic hyperglycemia with vanadate, but not phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84:892-899, 1989
18. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake: a dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
19. Rossetti L, M Hu: Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation: relation to the insulin-induced inhibition of hepatic glucose production. J Clin Invest 92:2963-2974, 1993
20. Karlander, S, Roovete A, Vranic M, Efendic S: Glucose and fructose-6-phosphate cycle in humans. Am J Physiol 251:E530-E536, 1986
21. Hostler KY, Landau BR: Estimation of the pentose cycle contribution to glucose metabolism in tissue in vivo. Biochemistry 6:2961-2964, 1967
22. 14C] glucose. Anal Biochem 25:486-499, 1968
23. Cohen P, Peehl DM, Stamey TA, Wilson K, Clemmons DR, Rosenfeld RG: Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76:830-835, 1993
24. Michal G: D-Glucose-6-phosphate. In Methods of Enzymatic Analysis. Vol. VI. Bergmeyer NU, Ed. Weinheim, VCH Publishers, 1985, p. 191-198
25. Giaccari A, Rossetti L: Isocratic high-performance liquid chromatographic determination of the concentration and specific activity of phosphoenolpyruvate and uridine diphosphate glucose in tissue extracts. J Chromatogr 497:69-78, 1989
26. Anumula KR, Taylor PB: Quantitative determination of phenyl isothiocyanate-derivatized amino sugars and amino sugar alcohols by high-performance liquid chromatography. Anal Biochem 197:113-120, 1991
27. Chan KC, Nicoll CS: Characterization of rat serum insulin-like growth factor binding proteins by two-dimensional gel electrophoresis: identification of a potentially novel form. Endocrinology 134:2574-2580, 1994
28. Cohen P, Rosenfeld RG: Physiological and clinical relevance of the IGF-BPs. Curr Opin Pediatr 6:462-467, 1994
29. Straus DS, Ooi GT, Orlowski CC, Rechler MM: Expression of the genes for insulin-like growth factor-1 (IGF-1), IGF-II, and IGF binding proteins-1 and 2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting. Endocrinology 128:518-525, 1991
30. Crook ED, Daniels MC, Smith TM, McClain DA: Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine:fructose-6-phosphate amidotransferase in Rat-1 fibroblasts. Diabetes 42:1289-1296, 1993
31. Barzilai N, Hawkins M, Angelov I, Hu M, Rossetti L: Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 45:1329-1335, 1996
32. Pillay TS, Xiao S, Olefsky JM: Glucose-induced phosphorylation of the insulin receptor. J Clin Invest 97:613-620, 1996
33. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Muhlhofer A, Berti L, Horikoshi H, Ullrich A, Haring H: Tumor necrosis factor-α and hyperglycemia-induced insulin resistance. J Clin Invest 97:1471-1477, 1996
34. Jacob RJ, Sherwin RS, Greenawalt K, Shulman GI: Simultaneous insulin-like growth factor-1 and insulin resistance in obese Zucker rats. Diabetes 41(6):691-697, 1992
35. Cascieri MA, Slater EE, Vicario PP, Green BG, Bayne ML, Saperstein R: Impaired insulin-like growth factor-1-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse. Diabetologia 32:342-347, 1989